Stevanato Group S.p.A. (NYSE:STVN) Announces Annual Dividend of €0.05

Posted by Micah Haroldson on Jun 9th, 2026

Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) announced an annual dividend on Friday, April 10th. Investors of record on Thursday, June 11th will be paid a dividend of 0.054 per share on Wednesday, July 29th. This represents a dividend yield of 29.0%. The ex-dividend date is Thursday, June 11th.

Stevanato Group has a dividend payout ratio of 8.2% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Stevanato Group to earn $0.80 per share next year, which means the company should continue to be able to cover its $0.06 annual dividend with an expected future payout ratio of 7.5%.

Stevanato Group Price Performance

Shares of STVN stock opened at €18.02 on Tuesday. The company has a quick ratio of 1.11, a current ratio of 1.63 and a debt-to-equity ratio of 0.21. Stevanato Group has a twelve month low of €12.89 and a twelve month high of €28.00. The company has a market cap of $5.46 billion, a P/E ratio of 30.54, a P/E/G ratio of 1.70 and a beta of 0.78. The business has a fifty day simple moving average of €16.49 and a 200 day simple moving average of €17.75.

Stevanato Group (NYSE:STVN – Get Free Report) last announced its quarterly earnings data on Friday, May 8th. The company reported €0.11 earnings per share for the quarter, missing the consensus estimate of €0.12 by (€0.01). Stevanato Group had a return on equity of 10.27% and a net margin of 11.76%.The business had revenue of €273.57 million for the quarter. During the same period in the prior year, the company posted $0.10 EPS. The firm’s revenue was up 6.6% compared to the same quarter last year. On average, sell-side analysts forecast that Stevanato Group will post 0.68 EPS for the current fiscal year.

Stevanato Group Company Profile

(Get Free Report)

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.